Algorithm 1 (n=645) | Algorithm 2 (n=189) | Algorithm 3 (n=286) | Algorithm 4 (n=226) | Algorithm 5 (n=355) | |
Continuous insulin use* beginning within 1 year of diabetes diagnosis | Diabetes diagnosed at age <30 years and continuous insulin use beginning within 1 year of diagnosis | Diabetes diagnosed at age <40 years and continuous insulin use beginning within 1 year of diagnosis | Self-report of type 1 diabetes and continuous insulin use beginning within 1 year of diagnosis | Self-report of type 1 diabetes and current insulin use | |
Weighted population size (millions) | 2.38 | 0.77 | 1.13 | 0.85 | 1.30 |
Percent (SE) | |||||
Overall | 10.2 (0.48) | 3.4 (0.29) | 4.9 (0.34) | 3.7 (0.29) | 5.6 (0.35) |
Age (years) | |||||
18–44 | 21.3 (1.93) | 15.3 (1.62) | 20.4 (1.83) | 14.0 (1.57) | 16.9 (1.83) |
45–64 | 9.7 (0.76) | 2.2 (0.35) | 3.7 (0.45) | 2.7 (0.38) | 4.4 (0.47) |
≥65 | 7.2 (0.59) | 0.8 (0.22) | 1.4 (0.26) | 1.4 (0.24) | 3.2 (0.37) |
Sex | |||||
Men | 11.4 (0.71) | 3.2 (0.41) | 5.2 (0.54) | 4.0 (0.43) | 5.9 (0.49) |
Women | 8.9 (0.63) | 3.5 (0.43) | 4.7 (0.47) | 3.3 (0.43) | 5.2 (0.54) |
Race/ethnicity | |||||
Non-Hispanic white | 10.4 (0.61) | 4.1 (0.39) | 5.4 (0.44) | 4.6 (0.41) | 7.0 (0.47) |
Non-Hispanic black | 12.9 (1.50) | 3.1 (0.79) | 5.6 (1.00) | 1.8 (0.57) | 3.3 (0.72) |
Non-Hispanic Asian | † | 0.1 (0.06) | 0.6 (0.55) | 1.6 (0.82) | † |
Hispanic | 8.7 (1.21) | 2.2 (0.64) | 4.1 (0.88) | 2.3 (0.69) | 3.5 (0.83) |
Mexican American | 6.4 (1.28) | 1.2 (0.51) | 2.6 (0.71) | 1.3 (0.49) | 1.6 (0.52) |
Age of diagnosis (years) | |||||
<20 | 32.4 (3.07) | 32.4 (3.07) | 32.4 (3.07) | 26.9 (2.99) | 33.1 (3.31) |
20–29 | 17.1 (2.44) | 17.1 (2.44) | 17.1 (2.44) | 9.9 (1.67) | 13.1 (1.90) |
30–39 | 11.7 (1.39) | ‡ | 11.7 (1.39) | 3.3 (0.68) | 6.9 (9.8) |
40–49 | 9.1 (1.00) | ‡ | ‡ | 1.5 (0.36) | 2.9 (0.51) |
50–59 | 7.1 (0.80) | ‡ | ‡ | 0.9 (0.28) | 1.8 (0.36) |
≥60 | 5.7 (0.73) | ‡ | ‡ | 0.7 (0.24) | 1.5 (0.40) |
Self-reported type | |||||
Type 1 diabetes | 35.0 (2.21) | 23.6 (2.1) | 27.9 (2.22) | 35.0 (2.21) | 53.4 (2.56) |
Type 2 diabetes | 7.5 (0.48) | 1.0 (0.18) | 2.2 (0.27) | ‡ | ‡ |
Body mass index (kg/m2) | |||||
<25.0 | 16.8 (1.57) | 8.8 (1.32) | 11.1 (1.45) | 10.2 (1.35) | 13.3 (1.54) |
25.0–29.9 | 9.7 (0.94) | 3.4 (0.53) | 4.5 (0.60) | 4.6 (0.64) | 6.6 (0.73) |
≥30.0 | 8.9 (0.63) | 2.1 (0.31) | 3.7 (0.43) | 1.5 (0.24) | 3.1 (0.35) |
Gestational diabetes among women who have been pregnant | |||||
No | 8.0 (0.73) | 2.5 (0.43) | 3.3 (0.47) | 2.6 (0.42) | 4.1 (0.51) |
Yes | 7.1 (1.24) | 4.0 (0.98) | 5.7 (1.09) | 1.5 (0.58) | 3.8 (0.94 |
Continuous insulin use within 1 year of diagnosis* | |||||
No | ‡ | ‡ | ‡ | ‡ | 2.0 (0.21) |
Yes | 100 | 32.8 (2.27) | 48.6 (2.46) | 35.8 (2.38) | 35.8 (2.38) |
Oral hypoglycemic medication | |||||
No | 21.1 (1.27) | 10.3 (0.92) | 12.7 (1.05) | 11.9 (1.00) | 16.5 (1.13) |
Yes | 6.1 (0.48) | 0.7 (0.18) | 2.0 (0.28) | 0.6 (0.15) | 1.5 (0.21) |
*Continuous insulin use implies current insulin use as well. Only those who report current insulin use are asked when they started insulin treatment.
†Data do not meet the National Center for Health Statistics Data Presentation Standards for Proportions.
‡Values are not applicable due to inclusion/exclusion criteria of the algorithm.